ESSA Pharma Inc. (EPIX)
- Previous Close
6.72 - Open
6.78 - Bid 5.01 x 200
- Ask 8.32 x 200
- Day's Range
6.18 - 6.96 - 52 Week Range
2.56 - 11.67 - Volume
102,359 - Avg. Volume
134,393 - Market Cap (intraday)
279.585M - Beta (5Y Monthly) 1.69
- PE Ratio (TTM)
-- - EPS (TTM)
-0.59 - Earnings Date May 7, 2024 - May 13, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
19.00
ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.
www.essapharma.comRecent News: EPIX
Performance Overview: EPIX
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: EPIX
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: EPIX
Valuation Measures
Market Cap
297.28M
Enterprise Value
155.54M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
2.11
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
-6.05
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-12.87%
Return on Equity (ttm)
-17.05%
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-25.8M
Diluted EPS (ttm)
-0.59
Balance Sheet and Cash Flow
Total Cash (mrq)
142.12M
Total Debt/Equity (mrq)
0.27%
Levered Free Cash Flow (ttm)
-15.17M
Research Analysis: EPIX
Analyst Price Targets
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Research Reports: EPIX
Daily – Vickers Top Buyers & Sellers for 11/17/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 01/06/2023
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 07/21/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Daily – Vickers Top Buyers & Sellers for 07/19/2022
The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.